Try Ask OE! Our NEW Advanced AI Enabled Search
Dive into the Largest Database of
Musculoskeletal Evidence
Make a selection below to explore our full database of 12 results matching: "Heparin"
ACE Reports
(12 Reports)
ACE Reports
Originals
(0 Articles)
Originals
Podcasts
(0 Videos)
Podcasts
Our Al driven High Impact metric predicts an article's future number of citations by considering the content of the article.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Open Advanced Search
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Exact search includes articles which contain all of the selected filters. Broad search includes articles that have at least one of the selected filters for each category.
Trauma
OTA 2022: Aspirin vs Low-Molecular-Weight Heparin for Thromboprophylaxis
OTA 2022: Aspirin vs Low-Molecular-Weight Heparin for Thromboprophylaxis
Peri-Operative
Aspirin Versus Low-Molecular-Weight Heparin For Thromboprophylaxis After Orthopaedic Surgery
Blood Coagul Fibrinolysis. 2024 01-Jun;():. 10.1097/MBC.0000000000001300
Aspirin Versus Low-Molecular-Weight Heparin For Thromboprophylaxis After Orthopaedic Surgery
Blood Coagul Fibrinolysis. 2024 01-Jun;():. 10.1097/MBC.0000000000001300
Peri-Operative
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major surgery
J Orthop Surg Res. 2024 01-Sep;():. 10.1186/s13018-024-05087-y
Effectiveness and safety of rivaroxaban or low-molecular-weight heparin in non-major surgery
J Orthop Surg Res. 2024 01-Sep;():. 10.1186/s13018-024-05087-y
Arthroplasty
Fondaparinux Sodium Vs Low-Molecular-Weight Heparin For Deep Vein Thrombosis During THA
J Musculoskelet Neuronal Interact. 2024 01-Jun;():.
Fondaparinux Sodium Vs Low-Molecular-Weight Heparin For Deep Vein Thrombosis During THA
J Musculoskelet Neuronal Interact. 2024 01-Jun;():.
Arthroplasty
Aspirin vs Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis after TKA
Int J Surg. 2023 01-Nov;():. 10.1097/JS9.0000000000000656
Aspirin vs Low-Molecular-Weight Heparin for Venous Thromboembolism Prophylaxis after TKA
Int J Surg. 2023 01-Nov;():. 10.1097/JS9.0000000000000656
Trauma
PREVENT CLOT Trial: Aspirin vs. Low Molecular Weight Heparin for Thromboprophylaxis After Fracture
N Engl J Med. 2022 01-Dec;():. 10.1056/NEJMoa2205973
PREVENT CLOT Trial: Aspirin vs. Low Molecular Weight Heparin for Thromboprophylaxis After Fracture
N Engl J Med. 2022 01-Dec;():. 10.1056/NEJMoa2205973
General Orthopaedics
Vapocoolant Spray Prior to Heparin Injection Reduces Pain in Lower Extremity Surgery Patients
Clin Nurs Res. 2021 01-Feb;():. 10.1177/1054773818825486
Vapocoolant Spray Prior to Heparin Injection Reduces Pain in Lower Extremity Surgery Patients
Clin Nurs Res. 2021 01-Feb;():. 10.1177/1054773818825486
General Orthopaedics
Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
PloS one. 2020 Aug-03;():. 10.1371/journal.pone.0235628
Low-Molecular Weight Heparin and Aspirin Provide Similar VTE Prevention in Trauma Fracture Patients
PloS one. 2020 Aug-03;():. 10.1371/journal.pone.0235628
Trauma
Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
Arthroscopy. 2014 Aug;30(8):987-96
This study has been identified as potentially high impact.
OE's AI-driven High Impact metric estimates the influence a paper is likely to have by integrating signals from both the journal in which it is published and the scientific content of the article itself.
Developed using state-of-the-art natural language processing, the OE High Impact model more accurately predicts a study's future citation performance than journal impact factor alone.
This enables earlier recognition of clinically meaningful research and helps readers focus on articles most likely to shape future practice.
Potential efficacy of low-molecular-weight heparin in preventing thromboembolic events
Arthroscopy. 2014 Aug;30(8):987-96
General Orthopaedics
Low-molecular-weight heparin prophylaxis may reduce DVT incidence after knee arthroscopy
Arthroscopy. 2014 Mar;30(3):406-12. doi: 10.1016/j.arthro.2013.12.021.
Low-molecular-weight heparin prophylaxis may reduce DVT incidence after knee arthroscopy
Arthroscopy. 2014 Mar;30(3):406-12. doi: 10.1016/j.arthro.2013.12.021.
Arthroplasty
THA: Heparin does not stop pelvic thrombi but may prevent ipsilateral femoral thrombi
J Arthroplasty. 2005 Jan;20(1):42-50
THA: Heparin does not stop pelvic thrombi but may prevent ipsilateral femoral thrombi
J Arthroplasty. 2005 Jan;20(1):42-50
Arthroplasty
Mobile compression device vs. heparin for prevention of thromboembolic events after THA
J Bone Joint Surg Am. 2010 Mar;92(3):527-35
Includes Author Interview
Mobile compression device vs. heparin for prevention of thromboembolic events after THA
J Bone Joint Surg Am. 2010 Mar;92(3):527-35